Nifty  22419.95  -150.40  (-0.67%)

Sensex  73730.16  -609.28  (-0.82%)

USDINR  83.35  0.02  (0.02%)

Vaishali Pharma Ltd
Registered Office:
706 to 709 7th Floor Aravali,Business Centre Borivali(W), Mumbai - 400092, Maharashtra, India.
Initial public offer consisting of fresh issue of 19,76,000 equity shares of face value of Rs. 10/- each fully paid for cash at a price of Rs. 72 per equity share (the "issue price") (including a share premium of Rs. 62 per equity share) aggregating up to Rs. 14.23 crores (the "issue"). of which 1,04,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 72/- per equity share, aggregating Rs. 0.75 crores will be reserved for subscription by the market maker to the issue (the "market maker reservation portion"). The issue less market maker reservation portion i.e. issue 18,72.000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 72/- per equity share, aggregating Rs. 13.48 crores is hereinafter referred to as the "net issue". The issue and the net issue will constitute 29.98% and 28.40% respectively of the fully diluted post issue paid up equity share capital of the company. The face value of equity shares is Rs.10/- each. The issue price is Rs.72/- and is 7.2 times the face value of the equity shares.
Issue
Opens On Closes On
07-Aug-17 10-Aug-17
Money Payable On
Application Allotment
72.00 0.00
Minimum Application for shares in Nos : 1600  Further Multiples of : 1600
()(Cr.) Lead Managers to the Issue
Project Cost () 14.23 Pantomath Capital Advisors Pvt Ltd
Project Financed through Current Offer () 14.23  
Post Issue Equity Share Capital () 6.59  
Issue Price () 72.00  
Projects
Working capital requirements
General corporate purpose
Promoted By
Atul Vasani
Jagruti Vasani
Listing At
NSE - SME
Registrar to the Issue